Filter
Safety, tolerability, pharmacokinetics, and efficacy of fenfluramine in combination with cannabidiol: results from an exploratory phase 1 study
Non-seizure benefits of long-term fenfluramine treatment in pediatric patients with Dravet syndrome
Fenfluramine efficacy trajectories in placebo or treatment groups from randomized controlled trial to open-label extension in patients with Lennox-Gastaut Syndrome
Onset and duration of adverse events in patients treated with fenfluramine in the Lennox-Gastaut Syndrome clinical trials
Safety and effectiveness of fenfluramine for the treatment of seizures in Lennox-Gastaut Syndrome: results from the final analysis of an open-label extension study
Prospective evaluation of non-seizure benefits related to treatment with fenfluramine in pediatric and adult patients with Dravet syndrome
Antiseizure medication regimen adjustment after fenfluramine initiation: lessons learned from European early access program in pediatric and adult patients with Dravet syndrome
Use of fenfluramine and cannabidiol in daily practice: a retrospective analysis of German prescription claims
Brivaracetam adjunctive therapy in pediatric and adult patients with focal-onset seizures in mid-European countries: 12-month, real-world outcomes from the BRIVA-REG study